Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 1048 entries
View as:

Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02024217 Org: User:
Start: 03/31/12 End: 08/31/15 Due: 08/31/16

A Model for Predicting the Efficacy of Conversion Therapy for Patients With Colorectal Cancer Liver Metastases by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA

Phase: N/A Priority: Normal
NCT ID: NCT03679039 Org: User:
Start: 09/20/18 End: 03/31/19 Due: 03/31/20

S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC）

Phase: N/A Priority: Normal
NCT ID: NCT03941561 Org: User:
Start: 01/01/19 End: 05/01/27 Due: 05/01/28

Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06684327 Org: User:
Start: 11/30/24 End: 12/30/27 Due: 12/30/28

Comparing the Efficacy of Sintilimab Plus Nab-POF Regimen, Sintilimab Plus XELOX Chemotherapy, and Lenvatinib, Sintilimab Plus XELOX Chemotherapy in the Treatment of HER2-negative, Metastatic Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06748508 Org: User:
Start: 12/25/24 End: 12/25/27 Due: 12/25/28

Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06503380 Org: User:
Start: 07/15/24 End: 06/10/27 Due: 06/10/28

Decision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT04831528 Org: User:
Start: 04/10/21 End: 06/30/26 Due: 06/30/27

Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05954078 Org: User:
Start: 08/01/23 End: 06/30/28 Due: 06/30/29

Effect of Sufentanil and Ropivacaine

Phase: N/A Priority: Normal
NCT ID: NCT02488291 Org: User:
Start: 04/30/14 End: 06/30/15 Due: 06/30/16

Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution

Phase: N/A Priority: Normal
NCT ID: NCT03255187 Org: User:
Start: 09/09/17 End: 01/13/18 Due: 01/13/19

Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)

Phase: N/A Priority: Normal
NCT ID: NCT01216111 Org: User:
Start: 01/01/11 End: 04/20/16 Due: 04/20/17

A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)

Phase: N/A Priority: Normal
NCT ID: NCT01655992 Org: User:
Start: 01/31/12 End: 10/31/17 Due: 10/31/18

Cryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01)

Phase: N/A Priority: Normal
NCT ID: NCT06860477 Org: User:
Start: 03/18/25 End: 03/15/28 Due: 03/15/29

Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01605305 Org: User:
Start: 09/30/08 End: 01/31/12 Due: 01/31/13

Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04706598 Org: User:
Start: 06/09/21 End: 12/31/24 Due: 12/31/25

ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT01810367 Org: User:
Start: 12/31/11 End: 12/31/15 Due: 12/31/16

Clinical Study on the Improvement of Diabetic Neuropathic Pain by Liraglutide

Phase: N/A Priority: Normal
NCT ID: NCT04137328 Org: User:
Start: 11/30/19 End: 11/30/22 Due: 11/30/23

Dose-adjusted EPOCH-R in MYC Positive DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT01914718 Org: User:
Start: 02/28/13 End: 12/31/17 Due: 12/31/18

Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT05057052 Org: User:
Start: 09/26/21 End: 09/25/26 Due: 09/25/27

Acute Health Effects of Traffic-Related Air Pollution Exposure

Phase: N/A Priority: Normal
NCT ID: NCT04153539 Org: User:
Start: 10/09/19 End: 12/31/26 Due: 12/31/27

Precision Medicine for Colorectal Cancer Liver Metastasis Guided by Multi-omics Data Under the Umbrella Theory

Phase: N/A Priority: Normal
NCT ID: NCT04525807 Org: User:
Start: 09/01/20 End: 09/01/22 Due: 09/01/23

Dexrazoxane as a Protective Agent in Anthracycline Treated Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00955890 Org: User:
Start: 06/30/09 End: 02/29/12 Due: 02/28/13

Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00568529 Org: User:
Start: 10/31/07 End: 02/28/10 Due: 02/28/11

Segmentectomy for Solid-dominant Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06634966 Org: User:
Start: 07/01/24 End: 06/30/27 Due: 06/30/28

The Safety and Efficacy of Multimodal Thermal Therapy in the Treatment of Early-stage Invasive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06635096 Org: User:
Start: 10/08/24 End: 10/07/26 Due: 10/07/27